# Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

> **NCT00421447** · — · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 58 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00421447
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2015-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421447, "Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00421447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
